Literatura académica sobre el tema "NEUROPROTECTANTS"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "NEUROPROTECTANTS".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "NEUROPROTECTANTS"
Palmer, Katharine J. y Joanne Dalton. "Neuroprotectants in Stroke". Drugs in R & D 1, n.º 1 (enero de 1999): 9–13. http://dx.doi.org/10.2165/00126839-199901010-00002.
Texto completoSchreihofer, D. A. "Phytoestrogens as neuroprotectants". Drugs of Today 45, n.º 8 (2009): 609. http://dx.doi.org/10.1358/dot.2009.45.8.1395520.
Texto completoShi, Ligen, Marcelo Rocha, Rehana K. Leak, Jingyan Zhao, Tarun N. Bhatia, Hongfeng Mu, Zhishuo Wei et al. "A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion". Journal of Cerebral Blood Flow & Metabolism 38, n.º 12 (7 de septiembre de 2018): 2073–91. http://dx.doi.org/10.1177/0271678x18798162.
Texto completoSharkey, John, Paul A. Jones, Jennifer F. McCarter y John S. Kelly. "Calcineurin Inhibitors as Neuroprotectants". CNS Drugs 13, n.º 1 (enero de 2000): 1–13. http://dx.doi.org/10.2165/00023210-200013010-00001.
Texto completoJeyaseelan, K., KY Lim y A. Armugam. "Neuroprotectants in stroke therapy". Expert Opinion on Pharmacotherapy 9, n.º 6 (abril de 2008): 887–900. http://dx.doi.org/10.1517/14656566.9.6.887.
Texto completoŠtolc, Svorad. "Indole derivatives as neuroprotectants". Life Sciences 65, n.º 18-19 (octubre de 1999): 1943–50. http://dx.doi.org/10.1016/s0024-3205(99)00453-1.
Texto completoKelly, J. S. y J. Sharkey. "Immunosuppressants-ligands as neuroprotectants". Transplantation Proceedings 33, n.º 3 (mayo de 2001): 2217–19. http://dx.doi.org/10.1016/s0041-1345(01)01945-5.
Texto completoMuir, K. W. y Ph A. Teal. "Why have neuroprotectants failed?" Journal of Neurology 252, n.º 9 (25 de agosto de 2005): 1011–20. http://dx.doi.org/10.1007/s00415-005-0933-6.
Texto completo&NA;. "Neuroprotectants for Parkinson's disease reviewed". Inpharma Weekly &NA;, n.º 1389 (mayo de 2003): 4. http://dx.doi.org/10.2165/00128413-200313890-00007.
Texto completoKLEIN, MICHAEL, SILVIA CALDERON y BELINDA HAYES. "Abuse Liability Assessment of Neuroprotectants". Annals of the New York Academy of Sciences 890, n.º 1 NEUROPROTECTI (diciembre de 1999): 515–25. http://dx.doi.org/10.1111/j.1749-6632.1999.tb08033.x.
Texto completoTesis sobre el tema "NEUROPROTECTANTS"
Boice, Ashley. "DEVELOPMENT OF SMALL MOLECULE NEUROPROTECTANTS". VCU Scholars Compass, 2018. https://scholarscompass.vcu.edu/etd/5372.
Texto completoJoshi, Kaushal V. "Novel Neuroprotectants for Sarin plus CBDP induced convulsions". Wright State University / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=wright1253321185.
Texto completoZhang, Zai Jun. "Pharmacological characterization of new neuroprotectants in Parkinson's disease models". Thesis, University of Macau, 2012. http://umaclib3.umac.mo/record=b2554086.
Texto completoNandasena, Charith. "Impact of neuroprotectants on behavioural and cognitive loss in neurodegenerative diseases". Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/17235.
Texto completoClarke, Allison Elizabeth. "Novel organic nitrates as possible neuroprotectants in an in vitro model of stroke in the rat hippocampus". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/MQ59369.pdf.
Texto completoFu, Qingling. "Characterization of novel neuroprotectants for rescuing retinal ganglion cell loss in an ocular hypertensive model of glaucoma". Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/HKUTO/record/B39557510.
Texto completoFu, Qingling y 付清玲. "Characterization of novel neuroprotectants for rescuing retinal ganglion cell loss in an ocular hypertensive model of glaucoma". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B39557510.
Texto completoWong, Raymond. "Progesterone as a neuroprotectant in stroke". Thesis, University of Nottingham, 2013. http://eprints.nottingham.ac.uk/13730/.
Texto completoPark, Han-A. "Natural Vitamin E, α-Tocotrienol, as a Neuroprotectant". The Ohio State University, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=osu1291061955.
Texto completoSawyer, Dale C. "The interactions of putative neuroprotectant compounds with NMDA ion channels". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/nq25152.pdf.
Texto completoLibros sobre el tema "NEUROPROTECTANTS"
Antkiewicz-Michaluk, Lucyna y Hans Rommelspacher, eds. Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-1542-8.
Texto completoIsoquinolines and beta-carbolines as neurotoxins and neuroprotectants: New vistas in Parkinson's disease therapy. New York: Springer, 2012.
Buscar texto completoRommelspacher, Hans y Lucyna Antkiewicz-Michaluk. Isoquinolines and Beta-Carbolines As Neurotoxins and Neuroprotectants: New Vistas in Parkinson's Disease Therapy. Springer, 2014.
Buscar texto completoReich, David L., Stephan A. Mayer y Suzan Uysal, eds. Neuroprotection in Critical Care and Perioperative Medicine. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190280253.001.0001.
Texto completoCapítulos de libros sobre el tema "NEUROPROTECTANTS"
Uhr, M., B. Moosmann y C. Behl. "Aromatic alcohols as neuroprotectants". En Alzheimer’s Disease — From Basic Research to Clinical Applications, 287–94. Vienna: Springer Vienna, 1998. http://dx.doi.org/10.1007/978-3-7091-7508-8_28.
Texto completoAndrews, Anne M., Greg A. Gerhardt, Lynette C. Daws, Mohammed Shoaib, Barbara J. Mason, Charles J. Heyser, Luis De Lecea et al. "Neuroprotectants: Novel Approaches for Dementias". En Encyclopedia of Psychopharmacology, 856–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_401.
Texto completoRhodes, Kenneth J. "Neuroprotectants: Novel Approaches for Dementias". En Encyclopedia of Psychopharmacology, 1073–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-36172-2_401.
Texto completoRhodes, Kenneth J. "Neuroprotectants: Novel Approaches for Dementias". En Encyclopedia of Psychopharmacology, 1–5. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27772-6_401-2.
Texto completoVetiska, Sandra M. y Michael Tymianski. "Neuroprotectants Targeting NMDA Receptor Signaling". En Handbook of Neurotoxicity, 1381–402. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-5836-4_168.
Texto completoDada, Tanuj, Parul Ichhpujani, Srinivasan Senthilkumari y Alain Bron. "Ocular Hypotensives and Neuroprotectants in Glaucoma". En Pharmacology of Ocular Therapeutics, 207–27. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-25498-2_7.
Texto completoGrotta, James C. y Lise A. Labiche. "Combination of Thrombolytic Therapy With Neuroprotectants". En Thrombolytic Therapy for Acute Stroke, 77–93. Totowa, NJ: Humana Press, 2005. http://dx.doi.org/10.1385/1-59259-933-8:77.
Texto completoAlkayed, Nabil J., Michael M. Wang y Patricia D. Hurn. "Reproductive Hormones as Neuroprotectants in Brain Injury". En Brain Injury, 295–315. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1721-4_14.
Texto completoBarreto, Andrew D. y James C. Grotta. "Combination of Thrombolytic Therapy with Antithrombotics and Neuroprotectants". En Thrombolytic Therapy for Acute Stroke, 65–80. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07575-4_3.
Texto completoLorenc-Koci, Elżbieta. "Two Faces of 1,2,3,4-Tetrahydroisoquinoline Mode of Action in the Mammalian Brain: Is It an Endogenous Neurotoxin or a Neuromodulator?" En Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants, 3–30. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-1542-8_1.
Texto completoActas de conferencias sobre el tema "NEUROPROTECTANTS"
Gourley, Paul L., P. Chen, R. G. Copeland, Judy K. Hendricks, Anthony E. McDonald, M. E. Keep y J. R. Karlsson. "Nanosqueezed light for probing mitochondria and calcium-induced membrane swelling for study of neuroprotectants". En Micromachining and Microfabrication, editado por Peter Woias y Ian Papautsky. SPIE, 2004. http://dx.doi.org/10.1117/12.532188.
Texto completoInformes sobre el tema "NEUROPROTECTANTS"
Gourley, Paul Lee, Robert Guild Copeland, Anthony Eugene McDonald, Judy K. Hendricks y Robert K. Naviaux. Quantum squeezed light for probing mitochondrial membranes and study of neuroprotectants. Office of Scientific and Technical Information (OSTI), enero de 2005. http://dx.doi.org/10.2172/921140.
Texto completoBahr, Ben A. Comparison of Novel and Known Neuroprotectants for Treating Exposure to Different Types of Toxins. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2002. http://dx.doi.org/10.21236/ada416987.
Texto completoBahr, Ben A. Comparison of Novel and Known Neuroprotectants for Treating Exposure to Different Types of Toxins. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2003. http://dx.doi.org/10.21236/ada419303.
Texto completoBahr, Ben A. Comparison of Novel and Known Neuroprotectants for Treating Exposure to Different Types of Toxins. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2000. http://dx.doi.org/10.21236/ada384358.
Texto completoSaukkonen, Jussi. Xenon as a Neuroprotectant in Traumatic Brain Injury. Fort Belvoir, VA: Defense Technical Information Center, marzo de 2012. http://dx.doi.org/10.21236/ada581238.
Texto completoSaukkonen, Jussi. Xenon as a Neuroprotectant in Traumatic Brain Injury. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2011. http://dx.doi.org/10.21236/ada601955.
Texto completoSaukkonen, Jussi y Bruce Kristal. Xenon as a Neuroprotectant in Traumatic Brain Injury. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2009. http://dx.doi.org/10.21236/ada547294.
Texto completo